22-Apr-2026
Abbott is the most oversold healthcare stock as Q1 earnings roll on
Seeking Alpha News (Wed, 22-Apr 8:26 AM ET)
PRNewswire (Mon, 13-Apr 9:00 AM ET)
Are OMEX, PEN, SNCY, CWAN Obtaining Fair Deals for their Shareholders?
PRNewswire (Fri, 10-Apr 1:41 PM ET)
Business Wire (Tue, 7-Apr 10:04 PM ET)
Globe Newswire (Thu, 2-Apr 12:35 PM ET)
Are EHAB, SLAB, PEN, SKYT Obtaining Fair Deals for their Shareholders?
PRNewswire (Tue, 31-Mar 11:19 AM ET)
PRNewswire (Mon, 30-Mar 1:35 PM ET)
Globe Newswire (Tue, 3-Mar 12:38 PM ET)
Are PEN, STKL, BCO, LNKB Obtaining Fair Deals for their Shareholders?
PRNewswire (Mon, 2-Mar 4:39 PM ET)
Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
PRNewswire (Wed, 25-Feb 1:00 PM ET)
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.
Penumbra trades on the NYSE stock market under the symbol PEN.
As of April 22, 2026, PEN stock price climbed to $332.21 with 1,128,829 million shares trading.
PEN has a beta of -0.32, meaning it tends to be less sensitive to market movements. PEN has a correlation of 0.02 to the broad based SPY ETF.
PEN has a market cap of $13.03 billion. This is considered a Large Cap stock.
Last quarter Penumbra reported $385 million in Revenue and $1.18 earnings per share. This beat revenue expectation by $21 million and exceeded earnings estimates by $.06.
In the last 3 years, PEN traded as high as $362.41 and as low as $148.00.
The top ETF exchange traded funds that PEN belongs to (by Net Assets): IJH, VTI, VB, VBK, VXF.
PEN has underperformed the market in the last year with a price return of +19.8% while the SPY ETF gained +36.3%. PEN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -7.3% and +0.3%, respectively, while the SPY returned +3.5% and +5.2%, respectively.
PEN support price is $324.95 and resistance is $329.05 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PEN shares will trade within this expected range on the day.